SCHEMBL26045668

SCHEMBL26045668

CC1(I)C2CCC1CN(C(C)(C)C)C2

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26044190 0.81 ATM (0.33) ATM
SCHEMBL26044187 0.73 KMT2A (0.31)
SCHEMBL20152082 0.71 ATM (0.33) ATM
SCHEMBL19756548 0.71 ATM (0.33) ATM
SCHEMBL24189185 0.70 ATM (0.32) ATM
SCHEMBL20152078 0.68 ATM (0.31) ATM
SCHEMBL25505212 0.68 ATM (0.35) ATM
SCHEMBL19756540 0.67
SCHEMBL12458738 0.67
SCHEMBL27117053 0.67 ATM (0.33) ATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023144297-A1 RIFAMYCIN DERIVATIVES FOR THE TREATMENT OF DISEASES BioVersys AG (CH) 2023-08-03 WO disclosed